Pharmaceutical

868540-17-4: Carfilzomib

Carfilzomib is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells.

Connecting the World
Serving the Future of Pharmaceutical and Healthcare.

About Us: Corporate culture; Corporate vision

Products: Pharmaceutical; Biomedical; Medical Nutrition & Dietary Supplements; Home Care & Health; Animal nutrition & Health; Chemical Industry

Careers: Join us; Vacancies

Contact Us: Contact us; Sample request

Copyright © 2024 Intermediate (Shanghai) Industrial Development Co., Ltd